On March 13, 2025, United Family Healthcare (UFH), a leading high-end private healthcare services company in China, announced that Warburg Pincus, a global private equity investment leader, would further increase its stake in UFH. Upon completion of the transaction, Warburg Pincus will become a significant shareholder of UFH and secure a seat on the board of directors, and Fosun Pharma will exit from UFH.

Wilson Sonsini represented Warburg Pincus in the transaction. The legal team was led by partner Jie Zhu and included Xuchao Dong, Chun Teng, and Athena Yu.

For more details, please refer to UFH’s announcement and Fosun Pharma’s public disclosure.